Antifungals Industry Revenue to Reach $44.96 Billion by 2030 with CAGR of 8.9% (2026-2030)


 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Potential Market Growth Rate of the Antifungals Market?
The antifungals market size has grown strongly in recent years. It will grow from $29.6 billion in 2025 to $31.98 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increase in hospital-acquired infections, widespread use of azoles, rising immunosuppressed population, established antifungal therapies, global burden of mycoses.

The antifungals market size is expected to see strong growth in the next few years. It will grow to $44.96 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in systemic fungal infections, antifungal resistance concerns, demand for safer therapies, expansion of hospital care, increased diagnosis rates. Major trends in the forecast period include rising prevalence of fungal infections, growing demand for broad-spectrum antifungals, expansion of topical antifungal treatments, increased use in immunocompromised patients, development of novel antifungal drug classes.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

What Are the Critical Growth Contributors in the Antifungals Market?
The increasing prevalence of fungal infections is expected to propel the growth of the antifungals market going forward. Fungal infections are diseases caused by the invasion and growth of fungi in or on the body which affects various parts of the body, including the skin, nails, lungs, and mucous membranes. The rising prevalence of fungal infections is due to climate change creating favorable conditions for fungi to spread and adapt to higher temperatures, increasing human exposure and infection risks. Antifungals play a crucial role in treating fungal diseases by inhibiting the growth and reproduction of fungi, either by disrupting their cell wall or membrane, blocking essential enzymatic processes, or interfering with their ability to synthesize vital components, thereby reducing fungal load, alleviating symptoms, and preventing the spread of infection within the body. For instance, in May 2025, according to the UK Health Security Agency, a UK-based government department, bloodstream infections caused by yeast increased by 4% in 2024 compared with 2023, rising from 2,170 reported cases to 2,247. Therefore, the increasing incidence of fungal infections is driving the growth of the antifungals market.

What Are the Emerging Segments in the Antifungals Market?
The antifungals market covered in this report is segmented –

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines
2) By Route of Administration: Oral, Parenteral, Topical
3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments:
1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin
2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole
3) By Polyenes: Amphotericin B, Nystatin
4) By Allylamines: Terbinafine, Naftifine

Which Trends Are Most Likely to Influence Antifungals Market Growth in the Next Decade?
Major companies operating in the antifungals market are focusing on product innovation and formulation such as long‑acting echinocandin therapies, to improve patient adherence, reduce dosing frequency, and address unmet clinical needs in invasive fungal infections. By extending the half-life and modifying pharmacokinetics, these next‑generation antifungals offer effective fungal suppression with more convenient administration schedules. For instance, in March 2023, Cidara Therapeutics, a US-based biotechnology company, along with Melinta Therapeutics (U.S.), announced FDA approval for REZZAYO (rezafungin for injection) for the treatment of candidemia and invasive candidiasis. Rezafungin is a once‑weekly echinocandin, offering non-inferior efficacy compared to daily caspofungin in clinical trials (ReSTORE Phase 3), while maintaining a comparable safety profile. The extended dosing potential of REZZAYO addresses a critical gap in antifungal therapy, improving treatment continuity and reducing hospital burden in acute‑care settings.

Which Companies Are Driving Innovation in the Antifungals Market?
Major companies operating in the antifungals market are Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

Get the full antifungals market report here:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Which Region Is Projected to Account for the Largest Share of the Antifungals Market?
North America was the largest region in the drugs for antifungals market in 2025. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Train And Components Market Report 2025 – Strategic Data for Growth and Expansion

Image
  Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the anticipated market size of the train and components industry over the next few years? The train and components market size has grown strongly in recent years. It will grow from $245.66 billion in 2024 to $266.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to economic conditions, urbanization, government investment, environmental concerns. The train and components market size is expected to see strong growth in the next few years. It will grow to $354.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to high-speed rail expansion, sustainable transport, electrification, freight rail expansion, regulatory compliance. Major trends in the forecast period include electrification and lightweighting, advan...
Read more

Construction Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts What is the current market size of the construction industry, and what growth rate is it expected to achieve? The construction market size has grown strongly in recent years. It will grow from $16152.39 billion in 2024 to $17045.95 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the increasing infrastructure development, the increase in renovation activities, rapid growth in the elderly population, and the rise in domestic manufacturing. The construction market size is expected to see strong growth in the next few years. It will grow to $21260.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising urbanization, increasing population growth, increasing government support, rising industrialization, and an increase ...
Read more

Guacamole Market Forecasted to Reach USD $1.97 Billion by 2029 at 9.1% CAGR

Image
 Get 30% Off Market Intelligence Reports With Code ONLINE30 – Track Global Tariffs, Economic Shifts, and Sector Transformations How Will the Market Growth Rate of the Guacamole Market Impact Future Demand? The guacamole market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increased demand for ready-to-eat snacks, availability of hass avocado varieties, expansion of fast food and casual dining, the influence of culinary trends and food blogging, and health-conscious consumer choices. The guacamole market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to expanding avocado production, focus on sustainable and ethical sourcing, health benefits of avocado consumption, global...
Read more